Rafarma Pharmaceuticals Stock Probability of Future Pink Sheet Price Finishing Over 0.099

RAFA Stock  USD 0.09  0.03  47.54%   
Rafarma Pharmaceuticals' future price is the expected price of Rafarma Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Rafarma Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Rafarma Pharmaceuticals Backtesting, Rafarma Pharmaceuticals Valuation, Rafarma Pharmaceuticals Correlation, Rafarma Pharmaceuticals Hype Analysis, Rafarma Pharmaceuticals Volatility, Rafarma Pharmaceuticals History as well as Rafarma Pharmaceuticals Performance.
  
Please specify Rafarma Pharmaceuticals' target price for which you would like Rafarma Pharmaceuticals odds to be computed.

Rafarma Pharmaceuticals Target Price Odds to finish over 0.099

The tendency of Rafarma Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 0.1  or more in 90 days
 0.09 90 days 0.1 
about 19.36
Based on a normal probability distribution, the odds of Rafarma Pharmaceuticals to move over $ 0.1  or more in 90 days from now is about 19.36 (This Rafarma Pharmaceuticals probability density function shows the probability of Rafarma Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Rafarma Pharmaceuticals price to stay between its current price of $ 0.09  and $ 0.1  at the end of the 90-day period is about 9.39 .
Given the investment horizon of 90 days Rafarma Pharmaceuticals has a beta of 0.14 indicating as returns on the market go up, Rafarma Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Rafarma Pharmaceuticals will be expected to be much smaller as well. Moreover Rafarma Pharmaceuticals has an alpha of 1.7008, implying that it can generate a 1.7 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Rafarma Pharmaceuticals Price Density   
       Price  

Predictive Modules for Rafarma Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rafarma Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0915.23
Details
Intrinsic
Valuation
LowRealHigh
0.000.0715.21
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Rafarma Pharmaceuticals. Your research has to be compared to or analyzed against Rafarma Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Rafarma Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Rafarma Pharmaceuticals.

Rafarma Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Rafarma Pharmaceuticals is not an exception. The market had few large corrections towards the Rafarma Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rafarma Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rafarma Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.70
β
Beta against Dow Jones0.14
σ
Overall volatility
0.03
Ir
Information ratio 0.11

Rafarma Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rafarma Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rafarma Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Rafarma Pharmaceuticals is way too risky over 90 days horizon
Rafarma Pharmaceuticals has some characteristics of a very speculative penny stock
Rafarma Pharmaceuticals appears to be risky and price may revert if volatility continues
Rafarma Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (14.85 K) with profit before overhead, payroll, taxes, and interest of 0.
Rafarma Pharmaceuticals generates negative cash flow from operations

Rafarma Pharmaceuticals Technical Analysis

Rafarma Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Rafarma Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rafarma Pharmaceuticals. In general, you should focus on analyzing Rafarma Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Rafarma Pharmaceuticals Predictive Forecast Models

Rafarma Pharmaceuticals' time-series forecasting models is one of many Rafarma Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rafarma Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Rafarma Pharmaceuticals

Checking the ongoing alerts about Rafarma Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rafarma Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Rafarma Pharmaceuticals is way too risky over 90 days horizon
Rafarma Pharmaceuticals has some characteristics of a very speculative penny stock
Rafarma Pharmaceuticals appears to be risky and price may revert if volatility continues
Rafarma Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (14.85 K) with profit before overhead, payroll, taxes, and interest of 0.
Rafarma Pharmaceuticals generates negative cash flow from operations

Other Information on Investing in Rafarma Pink Sheet

Rafarma Pharmaceuticals financial ratios help investors to determine whether Rafarma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rafarma with respect to the benefits of owning Rafarma Pharmaceuticals security.